Search

Search Constraints

You searched for: Author/Creator Sampath, Deepak

Search Results

1. Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα). Issue 4 (15th February 2020)

2. Conjugation of Indoles to Antibodies through a Novel Self‐Immolating Linker. Issue 19 (25th March 2018)

3. Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer. (15th October 2021)

4. Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility. Issue 3 (1st February 2015)

5. Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor. Issue 14 (14th July 2015)

6. Preclinical assessment of the ADME, efficacy and drug-drug interaction potential of a novel NAMPT inhibitor. (2nd September 2019)

7. Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid. (20th April 2015)

8. Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase. (1st March 2022)

9. Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. Issue 3 (17th January 2023)

10. Unexpected equivalent potency of a constrained chromene enantiomeric pair rationalized by co-crystal structures in complex with estrogen receptor alpha. Issue 7 (1st April 2019)